SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-041798
Filing Date
2018-08-03
Accepted
2018-08-03 08:32:26
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499549_10q.htm 10-Q 472022
2 EXHIBIT 10.2 tv499549_ex10-2.htm EX-10.2 115505
3 EXHIBIT 31.1 tv499549_ex31-1.htm EX-31.1 7487
4 EXHIBIT 31.2 tv499549_ex31-2.htm EX-31.2 7400
5 EXHIBIT 32.1 tv499549_ex32-1.htm EX-32.1 3567
6 EXHIBIT 32.2 tv499549_ex32-2.htm EX-32.2 3759
  Complete submission text file 0001144204-18-041798.txt   4912775

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT eyeg-20180630.xml EX-101.INS 1325602
8 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20180630.xsd EX-101.SCH 32626
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20180630_cal.xml EX-101.CAL 27697
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20180630_def.xml EX-101.DEF 261781
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20180630_lab.xml EX-101.LAB 290838
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20180630_pre.xml EX-101.PRE 291566
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 18990397
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1